Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domain

Huang, Fangjin1, Tanaka, Hisashi2,3,1, Knudsen, Beatrice S.4,5,1,3, Rutgers, Joanne K.4
1Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, USA
2Surgery, Cedars-Sinai Medical Center, Los Angeles, USA
3Samuel Oschin Cancer Research Institute (SOCCI), Cedars-Sinai Medical Center, Los Angeles, USA
4Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, USA
5Department of Pathology, University of Utah, Salt Lake City, USA

Tóm tắt

Mutations in the exonuclease domain of POLE, a DNA polymerase associated with DNA replication and repair, lead to cancers with ultra-high mutation rates. Most studies focus on intestinal and uterine cancers with POLE mutations. These cancers exhibit a significant immune cell infiltrate and favorable prognosis. We questioned whether loss of function of other DNA polymerases can cooperate to POLE to generate the ultramutator phenotype. We used cases and data from 15 cancer types in The Cancer Genome Atlas to investigate mutation frequencies of 14 different DNA polymerases. We tested whether tumor mutation burden, patient outcome (disease-free survival) and immune cell infiltration measured by ESTIMATE can be attributed to mutations in POLQ and POLZ/REV3L. Thirty six percent of colorectal, stomach and endometrial cancers with POLE mutations carried additional mutations in POLQ (E/Q), POLZ/REV3L (E/Z) or both DNA polymerases (E/Z/Q). The mutation burden in these tumors was significantly greater compared to POLE-only (E) mutant tumors (p < 0.001). In addition, E/Q, E/Z, and E/Q/Z mutant tumors possessed an increased frequency of mutations in the POLE exonuclease domain (p = 0.013). Colorectal, stomach and endometrial E/Q, E/Z, and E/Q/Z mutant tumors within TCGA demonstrated 100% disease-free survival, even if the POLE mutations occurred outside the exonuclease domain (p = 0.003). However, immune scores in these tumors were related to microsatellite instability (MSI) and not POLE mutation status. This suggests that the host immune response may not be the sole mechanism for prolonged disease-free survival of ultramutated tumors in this cohort. Results in this study demonstrate that mutations in POLQ and REV3L in POLE mutant tumors should undergo further investigation to determine whether POLQ and REV3L mutations contribute to the ultramutator phenotype and favorable outcome of patients with POLE mutant tumors.

Từ khóa


Tài liệu tham khảo

citation_journal_title=Nature.; citation_title=Integrated genomic characterization of endometrial carcinoma; citation_author=C Kandoth, N Schultz, AD Cherniack, R Akbani, Y Liu, H Shen, AG Robertson, I Pashtan, R Shen, CC Benz; citation_volume=497; citation_issue=7447; citation_publication_date=2013; citation_pages=67-73; citation_id=CR1 citation_journal_title=Nature.; citation_title=Comprehensive molecular characterization of human colon and rectal cancer; citation_author=N Cancer Genome Atlas; citation_volume=487; citation_issue=7407; citation_publication_date=2012; citation_pages=330-337; citation_id=CR2 citation_journal_title=J Natl Cancer Inst; citation_title=Prognostic significance of POLE proofreading mutations in endometrial cancer; citation_author=DN Church, E Stelloo, RA Nout, N Valtcheva, J Depreeuw, N Haar, A Noske, F Amant, IP Tomlinson, PJ Wild; citation_volume=107; citation_issue=1; citation_publication_date=2015; citation_pages=402; citation_id=CR3 citation_journal_title=Cancer.; citation_title=Polymerase varepsilon (POLE) mutations in endometrial cancer: clinical outcomes and implications for lynch syndrome testing; citation_author=CC Billingsley, DE Cohn, DG Mutch, JA Stephens, AA Suarez, PJ Goodfellow; citation_volume=121; citation_issue=3; citation_publication_date=2015; citation_pages=386-394; citation_id=CR4 citation_journal_title=Gynecol Oncol; citation_title=POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium; citation_author=B Meng, LN Hoang, JB McIntyre, MA Duggan, GS Nelson, CH Lee, M Kobel; citation_volume=134; citation_issue=1; citation_publication_date=2014; citation_pages=15-19; citation_id=CR5 citation_journal_title=PLoS One; citation_title=Phenotype of POLE-mutated endometrial cancer; citation_author=S Imboden, D Nastic, M Ghaderi, F Rydberg, TT Rau, MD Mueller, E Epstein, JW Carlson; citation_volume=14; citation_issue=3; citation_publication_date=2019; citation_id=CR6 citation_journal_title=Nat Rev Cancer; citation_title=A panoply of errors: polymerase proofreading domain mutations in cancer; citation_author=E Rayner, IC Gool, C Palles, SE Kearsey, T Bosse, I Tomlinson, DN Church; citation_volume=16; citation_issue=2; citation_publication_date=2016; citation_pages=71-81; citation_id=CR7 citation_journal_title=J Pathol; citation_title=Germline and somatic polymerase epsilon and delta mutations define a new class of hypermutated colorectal and endometrial cancers; citation_author=S Briggs, I Tomlinson; citation_volume=230; citation_issue=2; citation_publication_date=2013; citation_pages=148-153; citation_id=CR8 citation_journal_title=Dis Colon Rectum; citation_title=Polymerase proofreading-associated polyposis: a new, dominantly inherited syndrome of hereditary colorectal cancer predisposition; citation_author=JM Church; citation_volume=57; citation_issue=3; citation_publication_date=2014; citation_pages=396-397; citation_id=CR9 citation_journal_title=Genes Chromosom Cancer; citation_title=Genotyping of colorectal cancer for cancer precision medicine: results from the IPH Center for Molecular Pathology; citation_author=M Jesinghaus, N Pfarr, V Endris, M Kloor, AL Volckmar, R Brandt, E Herpel, A Muckenhuber, F Lasitschka, P Schirmacher; citation_volume=55; citation_issue=6; citation_publication_date=2016; citation_pages=505-521; citation_id=CR10 citation_journal_title=Hum Mol Genet; citation_title=DNA polymerase epsilon and delta exonuclease domain mutations in endometrial cancer; citation_author=DN Church, SE Briggs, C Palles, E Domingo, SJ Kearsey, JM Grimes, M Gorman, L Martin, KM Howarth, SV Hodgson; citation_volume=22; citation_issue=14; citation_publication_date=2013; citation_pages=2820-2828; citation_id=CR11 citation_journal_title=Nature.; citation_title=Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma; citation_author=AJ Bass, V Thorsson, I Shmulevich, SM Reynolds, M Miller, B Bernard, T Hinoue, PW Laird, C Curtis; citation_volume=513; citation_issue=7517; citation_publication_date=2014; citation_pages=202-209; citation_id=CR12 citation_journal_title=Virchows Arch; citation_title=Molecular pathological classification of colorectal cancer; citation_author=MF Muller, AE Ibrahim, MJ Arends; citation_volume=469; citation_issue=2; citation_publication_date=2016; citation_pages=125-134; citation_id=CR13 citation_journal_title=Eur J Cancer; citation_title=Hypermutated tumours in the era of immunotherapy: the paradigm of personalised medicine; citation_author=L Nebot-Bral, D Brandao, L Verlingue, E Rouleau, O Caron, E Despras, Y El-Dakdouki, S Champiat, S Aoufouchi, A Leary; citation_volume=84; citation_publication_date=2017; citation_pages=290-303; citation_id=CR14 citation_journal_title=J Pathol; citation_title=Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response; citation_author=D Temko, IC Gool, E Rayner, M Glaire, S Makino, M Brown, L Chegwidden, C Palles, J Depreeuw, A Beggs; citation_volume=245; citation_issue=3; citation_publication_date=2018; citation_pages=283-296; citation_id=CR15 citation_journal_title=N Engl J Med; citation_title=PD-1 blockade in tumors with mismatch-repair deficiency; citation_author=DT Le, JN Uram, H Wang, BR Bartlett, H Kemberling, AD Eyring, AD Skora, BS Luber, NS Azad, D Laheru; citation_volume=372; citation_issue=26; citation_publication_date=2015; citation_pages=2509-2520; citation_id=CR16 citation_journal_title=Gastroenterology.; citation_title=Immune response against Frameshift-induced Neopeptides in HNPCC patients and healthy HNPCC mutation carriers; citation_author=Y Schwitalle, M Kloor, S Eiermann, M Linnebacher, P Kienle, HP Knaebel, M Tariverdian, A Benner, DM Knebel; citation_volume=134; citation_issue=4; citation_publication_date=2008; citation_pages=988-997; citation_id=CR17 citation_journal_title=J Clin Invest; citation_title=Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer; citation_author=JM Mehnert, A Panda, H Zhong, K Hirshfield, S Damare, K Lane, L Sokol, MN Stein, L Rodriguez-Rodriquez, HL Kaufman; citation_volume=126; citation_issue=6; citation_publication_date=2016; citation_pages=2334-2340; citation_id=CR18 citation_journal_title=J Mol Biol; citation_title=Lesion bypass activity of DNA polymerase theta (POLQ) is an intrinsic property of the pol domain and depends on unique sequence inserts; citation_author=M Hogg, M Seki, RD Wood, S Doublie, SS Wallace; citation_volume=405; citation_issue=3; citation_publication_date=2011; citation_pages=642-652; citation_id=CR19 citation_journal_title=Nat Struct Mol Biol; citation_title=Mechanism of microhomology-mediated end-joining promoted by human DNA polymerase Theta; citation_author=T Kent, G Chandramouly, SM McDevitt, AY Ozdemir, RT Pomerantz; citation_volume=22; citation_issue=3; citation_publication_date=2015; citation_pages=230-237; citation_id=CR20 citation_journal_title=Nature.; citation_title=Homologous recombination-deficient tumors are hyper-dependent on POLQ-mediated repair; citation_author=R Ceccaldi, JC Liu, R Amunugama, I Hajdu, B Primack, MIR Petalcorin, KW O'Connor, PA Konstantinopoulos, SJ Elledge, SJ Boulton; citation_volume=518; citation_issue=7538; citation_publication_date=2015; citation_pages=258-262; citation_id=CR21 citation_journal_title=Nature.; citation_title=Mammalian polymerase theta promotes alternative NHEJ and suppresses recombination; citation_author=PA Mateos-Gomez, F Gong, N Nair, KM Miller, E Lazzerini-Denchi, A Sfeir; citation_volume=518; citation_issue=7538; citation_publication_date=2015; citation_pages=254-257; citation_id=CR22 citation_journal_title=DNA Repair (Amst); citation_title=DNA polymerase POLQ and cellular defense against DNA damage; citation_author=MJ Yousefzadeh, RD Wood; citation_volume=12; citation_issue=1; citation_publication_date=2013; citation_pages=1-9; citation_id=CR23 citation_journal_title=Oncotarget.; citation_title=Overexpression of POLQ confers a poor prognosis in early breast cancer patients; citation_author=GS Higgins, AL Harris, R Prevo, T Helleday, WG McKenna, FM Buffa; citation_volume=1; citation_issue=3; citation_publication_date=2010; citation_pages=175-184; citation_id=CR24 citation_journal_title=Nat Rev Clin Oncol; citation_title=Targeted therapies: DNA polymerase theta-a new target for synthetic lethality?; citation_author=D Killock; citation_volume=12; citation_issue=3; citation_publication_date=2015; citation_pages=125; citation_id=CR25 citation_journal_title=BMC Cancer; citation_title=A DNA repair variant in POLQ (c.-1060A > G) is associated to hereditary breast cancer patients: a case–control study; citation_author=APC Brandalize, L Schüler-Faccini, J-S Hoffmann, M Caleffi, C Cazaux, P Ashton-Prolla; citation_volume=14; citation_issue=1; citation_publication_date=2014; citation_pages=1-7; citation_id=CR26 citation_journal_title=Nat Rev Cancer; citation_title=DNA polymerases and cancer; citation_author=SS Lange, K Takata, RD Wood; citation_volume=11; citation_issue=2; citation_publication_date=2011; citation_pages=96-110; citation_id=CR27 citation_journal_title=DNA Repair (Amst); citation_title=Eukaryotic DNA polymerase zeta; citation_author=AV Makarova, PM Burgers; citation_volume=29; citation_publication_date=2015; citation_pages=47-55; citation_id=CR28 citation_journal_title=Breast Cancer Res Treat; citation_title=Genetic variation in genes encoding for polymerase zeta subunits associates with breast cancer risk, tumour characteristics and survival; citation_author=V Varadi, M Bevier, E Grzybowska, R Johansson, K Enquist, R Henriksson, D Butkiewicz, J Pamula-Pilat, K Tecza, K Hemminki; citation_volume=129; citation_issue=1; citation_publication_date=2011; citation_pages=235-245; citation_id=CR29 citation_journal_title=Oncol Rep; citation_title=REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells; citation_author=W Wang, W Sheng, C Yu, J Cao, J Zhou, J Wu, H Zhang, S Zhang; citation_volume=34; citation_issue=3; citation_publication_date=2015; citation_pages=1460-1468; citation_id=CR30 citation_journal_title=Oncogene.; citation_title=REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility; citation_author=S Zhang, H Chen, X Zhao, J Cao, J Tong, J Lu, W Wu, H Shen, Q Wei, D Lu; citation_volume=32; citation_issue=2; citation_publication_date=2013; citation_pages=242-250; citation_id=CR31 citation_journal_title=G3 (Bethesda); citation_title=Genetic Networks Required to Coordinate Chromosome Replication by DNA Polymerases alpha, delta, and epsilon in Saccharomyces cerevisiae; citation_author=M Dubarry, C Lawless, AP Banks, S Cockell, D Lydall; citation_volume=5; citation_issue=10; citation_publication_date=2015; citation_pages=2187-2197; citation_id=CR32 citation_journal_title=Nat Rev Genet; citation_title=DNA polymerases and human disease; citation_author=LA Loeb, RJ Monnat; citation_volume=9; citation_issue=8; citation_publication_date=2008; citation_pages=594-604; citation_id=CR33 citation_journal_title=Cancer Discov; citation_title=The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data; citation_author=E Cerami, J Gao, U Dogrusoz, BE Gross, SO Sumer, BA Aksoy, A Jacobsen, CJ Byrne, ML Heuer, E Larsson; citation_volume=2; citation_issue=5; citation_publication_date=2012; citation_pages=401-404; citation_id=CR34 citation_journal_title=Sci Signal; citation_title=Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal; citation_author=J Gao, BA Aksoy, U Dogrusoz, G Dresdner, B Gross, SO Sumer, Y Sun, A Jacobsen, R Sinha, E Larsson; citation_volume=6; citation_issue=269; citation_publication_date=2013; citation_pages=pl1; citation_id=CR35 citation_journal_title=Nucleic Acids Res; citation_title=The Pfam protein families database: towards a more sustainable future; citation_author=RD Finn, P Coggill, RY Eberhardt, SR Eddy, J Mistry, AL Mitchell, SC Potter, M Punta, M Qureshi, A Sangrador-Vegas; citation_volume=44; citation_issue=D1; citation_publication_date=2016; citation_pages=D279-D285; citation_id=CR36 citation_journal_title=Nat Commun; citation_title=Inferring tumour purity and stromal and immune cell admixture from expression data; citation_author=K Yoshihara, M Shahmoradgoli, E Martinez, R Vegesna, H Kim, W Torres-Garcia, V Trevino, H Shen, PW Laird, DA Levine; citation_volume=4; citation_publication_date=2013; citation_pages=2612; citation_id=CR37 Core R. Team: R: a language and environment for statistical computing. In. Vienna, Austria: R Foundation for statistical. Computing. 2015. Huang F, Ma Z, Pollan S, Yuan X, Swartwood S, Gertych A, Rodriguez M, Mallick J, Bhele S, Guindi M, et al. Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET. J Pathol: Clin Res. 2016:n/a-n/a https://doi.org/10.1002/cjp1002.1049 . citation_journal_title=Nucleic Acids Res; citation_title=TCGAbiolinks: an R/bioconductor package for integrative analysis of TCGA data; citation_author=A Colaprico, TC Silva, C Olsen, L Garofano, C Cava, D Garolini, TS Sabedot, TM Malta, SM Pagnotta, I Castiglioni; citation_volume=44; citation_issue=8; citation_publication_date=2016; citation_id=CR40 citation_journal_title=Nat Genet; citation_title=Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas; citation_author=C Palles, JB Cazier, KM Howarth, E Domingo, AM Jones, P Broderick, Z Kemp, SL Spain, E Guarino, I Salguero; citation_volume=45; citation_issue=2; citation_publication_date=2013; citation_pages=136-144; citation_id=CR41 citation_journal_title=Clin Cancer Res; citation_title=Endometrial carcinomas with POLE exonuclease domain mutations have a favorable prognosis; citation_author=MK McConechy, A Talhouk, S Leung, D Chiu, W Yang, J Senz, LJ Reha-Krantz, CH Lee, DG Huntsman, CB Gilks; citation_volume=22; citation_issue=12; citation_publication_date=2016; citation_pages=2865-2873; citation_id=CR42 citation_journal_title=J Clin Oncol; citation_title=Systematic review of microsatellite instability and colorectal cancer prognosis; citation_author=S Popat, R Hubner, RS Houlston; citation_volume=23; citation_issue=3; citation_publication_date=2005; citation_pages=609-618; citation_id=CR43 citation_journal_title=J Clin Pathol; citation_title=Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma; citation_author=K Garg, RA Soslow; citation_volume=62; citation_issue=8; citation_publication_date=2009; citation_pages=679-684; citation_id=CR44 citation_journal_title=Int J Gynecol Cancer; citation_title=Prognostic significance of POLE exonuclease domain mutations in high-grade Endometrioid endometrial Cancer on survival and recurrence: a subanalysis; citation_author=CC Billingsley, DE Cohn, DG Mutch, EM Hade, PJ Goodfellow; citation_volume=26; citation_issue=5; citation_publication_date=2016; citation_pages=933-938; citation_id=CR45 citation_journal_title=Cancer Metastasis Rev; citation_title=Do mutator mutations fuel tumorigenesis?; citation_author=EJ Fox, MJ Prindle, LA Loeb; citation_volume=32; citation_issue=3–4; citation_publication_date=2013; citation_pages=353-361; citation_id=CR46 citation_journal_title=Gynecol Oncol; citation_title=Polymerase epsilon (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients; citation_author=S Bellone, F Centritto, J Black, C Schwab, D English, E Cocco, S Lopez, E Bonazzoli, F Predolini, F Ferrari; citation_volume=138; citation_issue=1; citation_publication_date=2015; citation_pages=11-17; citation_id=CR47 citation_journal_title=Nat Genet; citation_title=Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers; citation_author=A Shlien, BB Campbell, R Borja, LB Alexandrov, D Merico, D Wedge, P Loo, PS Tarpey, P Coupland, S Behjati; citation_volume=47; citation_issue=3; citation_publication_date=2015; citation_pages=257-262; citation_id=CR48 citation_journal_title=Cancer Cell; citation_title=Comparative molecular analysis of gastrointestinal adenocarcinomas; citation_author=Y Liu, NS Sethi, T Hinoue, BG Schneider, AD Cherniack, F Sanchez-Vega, JA Seoane, F Farshidfar, R Bowlby, M Islam; citation_volume=33; citation_issue=4; citation_publication_date=2018; citation_pages=721-735; citation_id=CR49 citation_journal_title=Clin Cancer Res; citation_title=POLE proofreading mutations elicit an antitumor immune response in endometrial Cancer; citation_author=IC Gool, FA Eggink, L Freeman-Mills, E Stelloo, E Marchi, M Bruyn, C Palles, RA Nout, CD Kroon, EM Osse; citation_volume=21; citation_issue=14; citation_publication_date=2015; citation_pages=3347-3355; citation_id=CR50 citation_journal_title=JAMA Oncol; citation_title=Association of Polymerase e-mutated and microsatellite-instable endometrial cancers with Neoantigen load, number of tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1; citation_author=BE Howitt, SA Shukla, LM Sholl, LL Ritterhouse, JC Watkins, S Rodig, E Stover, KC Strickland, AD D'Andrea, CJ Wu; citation_volume=1; citation_issue=9; citation_publication_date=2015; citation_pages=1319-1323; citation_id=CR51 citation_journal_title=Mod Pathol; citation_title=Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations; citation_author=YR Hussein, B Weigelt, DA Levine, JK Schoolmeester, LN Dao, BL Balzer, G Liles, B Karlan, M Kobel, CH Lee; citation_volume=28; citation_issue=4; citation_publication_date=2015; citation_pages=505-514; citation_id=CR52 citation_journal_title=Histopathology.; citation_title=Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy; citation_author=S Bakhsh, M Kinloch, LN Hoang, RA Soslow, M Kobel, CH Lee, JN McAlpine, MK McConechy, CB Gilks; citation_volume=68; citation_issue=6; citation_publication_date=2016; citation_pages=916-924; citation_id=CR53 citation_journal_title=J Pathol; citation_title=Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review; citation_author=K Nosho, Y Baba, N Tanaka, K Shima, M Hayashi, JA Meyerhardt, E Giovannucci, G Dranoff, CS Fuchs, S Ogino; citation_volume=222; citation_issue=4; citation_publication_date=2010; citation_pages=350-366; citation_id=CR54 citation_journal_title=Oncoimmunology.; citation_title=Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden; citation_author=J Budczies, A Seidel, P Christopoulos, V Endris, M Kloor, B Gyorffy, B Seliger, P Schirmacher, A Stenzinger, C Denkert; citation_volume=7; citation_issue=12; citation_publication_date=2018; citation_id=CR55 citation_journal_title=Nat Commun; citation_title=Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration; citation_author=M Smid, FG Rodriguez-Gonzalez, AM Sieuwerts, R Salgado, WJ Prager-Van der Smissen, MV Vlugt-Daane, A Galen, S Nik-Zainal, J Staaf, AB Brinkman; citation_volume=7; citation_publication_date=2016; citation_pages=12910; citation_id=CR56 citation_journal_title=Cell.; citation_title=Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of Cancer; citation_author=KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, AM Taylor, AD Cherniack, V Thorsson; citation_volume=173; citation_issue=2; citation_publication_date=2018; citation_pages=291-304; citation_id=CR57